[DE] DIPHENYLAMINSUBSTITUIERTE SALICYLTHIAZOLDERIVATE UND VERWANDTE VERBINDUNGEN ALS PHOSPHOTYROSINPHOSPHATASE 1B (PTP1B) HEMMER ZUR VERWENDUNG ALS BLUTZUCKERSENKENDE WIRKSTOFFE ZUR BEHANDLUNG VON DIABETES [EN] DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOTYROSINE PHOSPHATASE 1B (PTP1B) INHIBITORS FOR USING AS BLOOD-SUGAR DECREASING ACTIVE INGREDIENTS FOR TREATING DIABETES [FR] DERIVES DE SALICYLTHIAZOL SUBSTITUES PAR DIPHENYLAMINE ET COMPOSES APPARENTES SERVANT D'INHIBITEURS DE LA PHOSPHOTYROSINE PHOSPHATASE 1B (PTP1B) DESTINES A ETRE UTILISES EN TANT QUE PRINCIPES ACTIFS ABAISSANT LE TAUX DE SUCRE DANS LE SANG POUR LE TRA
[DE] DIPHENYLAMINSUBSTITUIERTE SALICYLTHIAZOLDERIVATE UND VERWANDTE VERBINDUNGEN ALS PHOSPHOTYROSINPHOSPHATASE 1B (PTP1B) HEMMER ZUR VERWENDUNG ALS BLUTZUCKERSENKENDE WIRKSTOFFE ZUR BEHANDLUNG VON DIABETES [EN] DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOTYROSINE PHOSPHATASE 1B (PTP1B) INHIBITORS FOR USING AS BLOOD-SUGAR DECREASING ACTIVE INGREDIENTS FOR TREATING DIABETES [FR] DERIVES DE SALICYLTHIAZOL SUBSTITUES PAR DIPHENYLAMINE ET COMPOSES APPARENTES SERVANT D'INHIBITEURS DE LA PHOSPHOTYROSINE PHOSPHATASE 1B (PTP1B) DESTINES A ETRE UTILISES EN TANT QUE PRINCIPES ACTIFS ABAISSANT LE TAUX DE SUCRE DANS LE SANG POUR LE TRA
DIPHENYLAMINSUBSTITUIERTE SALICYLTHIAZOLDERIVATE UND VERWANDTE VERBINDUNGEN ALS PHOSPHOTYROSINPHOSPHATASE 1B (PTP1B) HEMMER ZUR VERWENDUNG ALS BLUTZUCKERSENKENDE WIRKSTOFFE ZUR BEHANDLUNG VON DIABETES
申请人:Sanofi-Aventis Deutschland GmbH
公开号:EP1771426B1
公开(公告)日:2007-12-19
DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOTYROSINE PHOSPHATASE 1B (PTB1B) INHIBITORS FOR USING AS BLOOD-SUGAR DECREASING ACTIVE INGREDIENTS FOR TREATING DIABETES
申请人:Petry Stefan
公开号:US20070191441A1
公开(公告)日:2007-08-16
The invention therefore relates to compounds of the formula I
in which the variables are as defined in the specification, to pharmaceutical compositions containing them and to their use for therapeutically lowering blood glucose levels.